On August 2, 2021 Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases, reported that company management will participate in the following upcoming investor events and conferences (Press release, Xencor, AUG 2, 2021, View Source [SID1234585569]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Bernstein CD28 Day
Presentation: Monday, August 9, 1:00 p.m. ET (10:00 a.m. PT)
2021 Wedbush PacGrow Healthcare Virtual Conference
Panel: Tuesday, August 10, 1:10 p.m. ET (10:10 a.m. PT)
BTIG Virtual Biotechnology Conference 2021
Presentation: Tuesday, August 10, 3:30 p.m. ET (12:30 p.m. PT)
Canaccord Genuity 41st Annual Growth Conference
Presentation: Wednesday, August 11, 4:30 p.m. ET (1:30 p.m. PT)
Piper Sandler Virtual West Coast Bus Tour
Presentation: Thursday, August 12, 4:00 p.m. ET (1:00 p.m. PT)
A webcast of the presentation at the Canaccord conference will be available under "Events & Presentations" in the Investors section of the Company’s website located at www.xencor.com. Following the webcast, a replay will be archived on the website approximately for at least 30 days.